ALS ONE Merges with ALS Network to Accelerate Research and Care Nationwide
Event summary
- ALS ONE will integrate with ALS Network to scale ALS research and care initiatives nationwide.
- The merger aims to accelerate research funding, expand technology-driven patient care, and maintain support for Massachusetts-based ALS research partners.
- ALS ONE board members Mark Sullivan and Scott Gosnell will join the ALS Network Board of Directors.
- The integration is expected to complete in 2026, pending regulatory approvals.
The big picture
The merger aligns two key ALS organizations to leverage technology, corporate partnerships, and research collaboration for faster progress in treatment and care. This strategic move reflects a broader trend in healthcare toward consolidating resources to address complex diseases more efficiently. The integration could set a precedent for how non-profits and research institutions collaborate to scale impact.
What we're watching
- Integration Execution
- The pace at which ALS ONE and ALS Network consolidate operations will determine the speed of research and care advancements.
- Funding Expansion
- Whether the merger unlocks greater corporate funding for ALS research through Salesforce and other partners.
- National Scaling
- How the combined entity will balance regional commitments with nationwide expansion of ALS care and research initiatives.
Related topics